Evaluating the efficacy of whole genome sequencing in predicting susceptibility profiles for first-line antituberculosis drugs
Clinical Microbiology and Infection · 2025
DOI: 10.1016/j.cmi.2024.09.024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Microbiology and Infection, 2025. Verfasst von Arash Ghodousi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Vita-Salute San Raffaele University, Milan, Italy; Division of Immunology, Transplantation, and Infectious Diseases, IRCCS San Raffaele Scientific In…. Hauptthemen laut MEDLINE: Antitubercular Agents, Mycobacterium tuberculosis, Whole Genome Sequencing, Microbial Sensitivity Tests. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministero della Salute.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vita-Salute San Raffaele University, Milan, Italy; Division of Immunology, Transplantation, and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
- Division of Immunology, Transplantation, and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
- Regional TB Reference Centre and Laboratory, Villa Marelli Institute/Niguarda Hospital, Milano, Italy; Microbiological Analysis Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
- Microbiological Analysis Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
- Department of Infectious and Tropical Diseases, Collaborating Centre for TB Elimination, University of Brescia, Brescia, Italy.
- Regional TB Reference Centre and Laboratory, Villa Marelli Institute/Niguarda Hospital, Milano, Italy.
Förderung
- Ministero della Salute
Zitieren
APA
Ghodousi, A., Omrani, M., Torri, S., Teymouri, H., Russo, G., Vismara, C., Matteelli, A., Codecasa, L. R., & Cirillo, D. M. (2025). Evaluating the efficacy of whole genome sequencing in predicting susceptibility profiles for first-line antituberculosis drugs. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2024.09.024
Vancouver
Ghodousi A, Omrani M, Torri S, Teymouri H, Russo G, Vismara C, et al. Evaluating the efficacy of whole genome sequencing in predicting susceptibility profiles for first-line antituberculosis drugs. Clinical Microbiology and Infection. 2025. doi:10.1016/j.cmi.2024.09.024
BibTeX
@article{Ghodousi2025,
author = {Ghodousi, Arash and Omrani, Maryam and Torri, Stefania and Teymouri, Hedyeh and Russo, Giulia and Vismara, Chiara and Matteelli, Alberto and Codecasa, Luigi Ruffo and Cirillo, Daniela Maria},
title = {Evaluating the efficacy of whole genome sequencing in predicting susceptibility profiles for first-line antituberculosis drugs},
journal = {Clinical Microbiology and Infection},
year = {2025},
doi = {10.1016/j.cmi.2024.09.024}
}
EUVIMED